Business Wire4h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...
Post-Chevron DOGE: Is This the End of Federal Regulation?
The Supreme Court's Chevron decision last year shifted regulatory oversight to Congress. How could that impact the work of ...